News Search Results
Mar 11, 2025, 10:00 ET Robotic Radiotherapy Market is expected to generate a revenue of USD 2.95 Billion by 2032, Globally, at 11.6% CAGR: Verified Market Research®
Global Biotechnology Contract Manufacturing (Biopharmaceutical Manufacturing) Market Size by Service (Formulation & Fill-finish, Manufacturing, Packaging &
More news about: Verified Market Research
Mar 11, 2025, 09:20 ET WuXi XDC and AbTis Announce Strategic Partnership to Advance Next-Generation ADCs
conjugates (ADCs) and other bioconjugates (XDCs), today announced the signing of a Memorandum of Understanding (MOU) with AbTis, a leading ADC biotechnology company based in South Korea. This partnership brings together AbTis' proprietary site-selective conjugation platform
More news about: WuXi XDC
Mar 11, 2025, 09:00 ET Centivax and Emery Pharma Partner to Accelerate Universal Vaccine Clinical Readiness
FRANCISCO, Calif., March 11, 2025 /PRNewswire/ -- Centivax, a biotechnology company that develops broad-spectrum vaccines to combat rapidly evolving pathogens, has announced a strategic collaboration with Emery Pharma, a
More news about: Centivax
Mar 11, 2025, 08:46 ET Culture Summit Abu Dhabi Returns Under the Theme 'Culture for Humanity and Beyond'
a confident future. Day two will explore, 'the new frontiers of a post-human environment'. As advancements in technology, including AI, biotechnology, and environmental studies redefine the essence of humanity, the sessions on this day will examine how culture can ensure these changes enhance
More news about: Department of Culture and Tourism - Abu Dhabi
Mar 11, 2025, 08:45 ET In preparation of Phase II studies, Right Brain Bio signs Manufacturing Agreement with Suven Pharmaceuticals for RB-190 to Target the Root Cause of Parkinson's Disease
March 11, 2025 /PRNewswire/ -- Right Brain Bio, a biotechnology company pioneering treatments for complex diseases, today announced a manufacturing agreement with Suven Pharmaceuticals, a technology-driven global
More news about: Right Brain Bio, Inc.
Mar 11, 2025, 08:41 ET Culture Summit Abu Dhabi Returns Under the Theme 'Culture for Humanity and Beyond'
a confident future. Day two will explore, 'the new frontiers of a post-human environment'. As advancements in technology, including AI, biotechnology, and environmental studies redefine the essence of humanity, the sessions on this day will examine how culture can ensure these changes enhance
More news about: Department of Culture and Tourism - Abu Dhabi
Mar 11, 2025, 08:34 ET Dongguk University Researchers Create Clove Essential Oil-Based Pickering Emulsions
breakthrough, a team of researchers led by Jun-Won Kang, an Assistant Professor in the Department of Food Science and Biotechnology at Dongguk University, has come up with a novel clove essential oil-based Pickering emulsion formulation with enhanced antibacterial properties.
More news about: Dongguk University
Mar 11, 2025, 08:03 ET Integral Molecular Launches Paratope-PLUS™, a CDR-Scanning Service to Support Robust Patent Claims and Antibody Engineering
Nature Biotechnology1.
More news about: Integral Molecular
Mar 11, 2025, 08:00 ET ReParris Launches to Pioneer Regenerative Therapies for Age-Related Diseases, Addressing a $7 Trillion Healthcare Crisis
model for human longevity interventions. This program could accelerate clinical insights and de-risk future human trials.The longevity biotechnology market is projected to reach
More news about: ReParris
Mar 11, 2025, 08:00 ET WearOptimo Introduces World-Class Advisory Board to Further Advance Microwearable Sensor Technology for Precision Health Monitoring
Microwearable sensors for hydration and biomarker monitoring, today introduced its Advisory Board comprised of globally recognized experts in biotechnology, healthcare, regulatory affairs, and venture investment.
More news about: WearOptimo
Mar 11, 2025, 08:00 ET Apnimed Appoints Kevin R. Lind as Non-Executive Chairman of the Board of Directors
Kevin to Apnimed's Board," said Larry Miller, MD, Chief Executive Officer of Apnimed. "His proven leadership in biotechnology and corporate strategy will provide invaluable insights as we approach Phase 3 clinical trial results for AD109 and prepare for its potential commercial
More news about: Apnimed, Inc.
Mar 11, 2025, 07:00 ET Armata Pharmaceuticals Announces that CEO Dr. Deborah Birx Will Deliver a Presentation at the 7th Annual Bacteriophage Therapy Summit
March 11, 2025 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat
More news about: Armata Pharmaceuticals, Inc.
Mar 11, 2025, 06:59 ET Q32 Bio Reports Fourth Quarter 2024 Financial Results and Provides Corporate Update
March 11, 2025 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, today reported financial results for the quarter ended
More news about: Q32 Bio
Mar 10, 2025, 16:00 ET Protecting Women's Health: Visionary's Precision Cervical Cancer Screening Public Welfare Activity Brings Health Blessings to Women
USA, Inc., and co-organized by Yiqijia Group Co., Ltd. and (Canada) Visionary Biotechnology Group, etc. The attending guests included Hong Kong Councilors Hung Kam-in and Kan Ming-tung, Chairman of
More news about: Visionary Holdings Inc
Mar 10, 2025, 15:53 ET Christopher Wurster Joins Rubin and Rudman's Labor & Employment Group
Rubin and Rudman serves national and international companies, including large public companies and closely held businesses; real estate developers; biotechnology, pharmaceutical and medical device makers; regulated industries, public entities and municipalities; insurance companies and their insureds; educational
More news about: Rubin and Rudman
Mar 10, 2025, 15:02 ET Syngene Acquires its First Manufacturing Facility in the US
NSE: SYNGENE, ISIN: INE 398R01022) is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. Syngene's more than 5600 scientists offer both skills and the capacity
More news about: Syngene International
Mar 10, 2025, 11:29 ET Flagship Pioneering Unveils Lila Sciences to Build Superintelligence in Science
Sana Biotechnology (NASDAQ: SANA),
More news about: Flagship Pioneering
Mar 10, 2025, 11:00 ET TCI Biotech Announces Strong 2024 Financial Performance, Sets Sights on Global Growth in 2025
March 10, 2025 /PRNewswire/ -- TCI Biotech (TCI Co., Ltd.) (TWSE: 8436), a leading CDMO+ innovator in health food and skincare biotechnology, has released its consolidated financial results for the fiscal year ending December 31, 2024. The company reported
More news about: TCI; TCI Bio
Mar 10, 2025, 10:00 ET Daelight Solutions Achieves Veeva Premier Services Partner Level for Veeva Development Cloud
Solutions' continued commitment to providing exceptional services and expertise for Veeva's cloud-based software, empowering pharmaceutical and biotechnology organizations to optimize their operations and accelerate innovation.
More news about: Daelight Solutions
Mar 10, 2025, 09:13 ET FDA Accepts Biologics License Application for Duchenne Muscular Dystrophy Cardiomyopathy Treatment
wespeakduchenne.com. About Capricor Therapeutics, Inc.Capricor (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapeutics to redefine the treatment landscape for rare diseases. Capricor
More news about: NS Pharma, Inc.
Mar 10, 2025, 09:03 ET Growing Matters' BeSure! Campaign Returns to Promote Good Stewardship Practices This Season
the United States. CropLife America's member companies produce, sell, and distribute virtually all the necessary and vital pesticide and biotechnology products used by American farmers.
More news about: Growing Matters
Mar 10, 2025, 08:53 ET Reduction of Chemotherapy Associated Accelerated Aging by ImmortaSome™ Personalized Exosome Rejuvenation
provides means of reducing side effects of cancer therapies, as well as potentially will be applicable to aging caused by other means. "As a biotechnology corporation we need to identify as quickly as possible the therapeutic potency of our products," said Dr. Boris Reznik,
More news about: Immorta Bio Inc.
Mar 10, 2025, 08:30 ET Anixa Biosciences 2025 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it will host its 2025 Annual Meeting of Stockholders (the "Meeting")
More news about: Anixa Biosciences, Inc.
Mar 10, 2025, 08:05 ET Rigel Appoints Mark W. Frohlich, M.D. to Board of Directors
development pipeline and grow our portfolio." Dr. Frohlich currently serves as chief executive officer of Indapta Therapeutics, a privately-held biotechnology company focused on developing and bringing to market allogenic natural killer cell therapies to treat the still unmet medical needs of patients
More news about: Rigel Pharmaceuticals, Inc.
Mar 10, 2025, 07:30 ET Versatope Adds New Board Members
Mass., March 10, 2025 /PRNewswire/ -- Versatope Therapeutics Incorporated, a biotechnology company developing vaccines and immuno-therapeutics announced today Edward Jordan and Sam
More news about: Versatope Therapeutics, Incorporated